Megan Rosengarten's most recent trade in Neuronetics Inc was a trade of 25,000 Common Stock done . Disclosure was reported to the exchange on May 30, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Neuronetics Inc | Megan Rosengarten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 110,890 (0%) | 0% | - | Common Stock | |
Neuronetics Inc | Megan Rosengarten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 36,364 | 85,890 (0%) | 0% | - | Common Stock | |
Neuronetics Inc | Megan Rosengarten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 38,910 | 49,526 (0%) | 0% | - | Common Stock | |
Neuronetics Inc | Megan Rosengarten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 10,616 | 10,616 (0%) | 0% | - | Common Stock |